To provide you with a better experience, our website uses cookies. To continue browsing, you please accept our cookies policy.

J'accepte

Cookies informations

Our site uses tools, such as cookies, to analyse and improve your experience. You can unsubscribe from these follow-ups:

Statistics

Nous utilisons des outils, tels que Google Analytics, pour suivre le trafic Web et vérifier l'efficacité de notre site.

Essential

Cookies requis pour les services essentiels et les fonctionnalités telles que les formulaires de connexion, l'intégration du panier et le contrôle d'accès. Sans eux, notre site Web ne peut pas fonctionner correctement et nous ne pouvons fournir aucun service. La désactivation n'est pas disponible.

These parameters will be stored for 24 hours

Media Room

Our last news

IRE ELiT submitted Drug Master File (DMF) to the U.S. Food and Drug Administration (FDA) for the 100 mCi Ge68/Ga68 Galli Eo® generator.
IRE ELiT submitted Drug Master File (DMF) to the U.S. Food and Drug Administration (FDA) for the 100 mCi Ge68/Ga68 Galli Eo® generator.
More information
IRE submits its request for a single permit for the construction of a 100% Walloon cyclotron
IRE submits its request for a single permit for the construction of a 100% Walloon cyclotron
More information
IRE ELiT and ROTOP Pharmaka enter into a distribution partnership in Germany for Germanium-68/Gallium-68 generator
IRE ELiT and ROTOP Pharmaka enter into a distribution partnership in Germany for Germanium-68/Gallium-68 generator
More information
IRE ELiT and Telix Pharmaceuticals enter into a distribution partnership for prostate cancer imaging
IRE ELiT and Telix Pharmaceuticals enter into a distribution partnership for prostate cancer imaging
More information
IRE produces a first commercial batch of Mo-99 LEU
IRE produces a first commercial batch of Mo-99 LEU
More information
IRE and SCK CEN Partnership on lutetium-177production
IRE and SCK CEN Partnership on lutetium-177production
More information